Nektar Therapeutics (NKTR) Earnings

NKTR Earnings Reports

Positive Surprise Ratio

NKTR beat 34 of 43 last estimates.

79%

Next Report

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

$10.48M

-$2.11

Implied change from Q2 26 (Revenue/ EPS)

+3.44%

+71.54%

Implied change from Q3 25 (Revenue/ EPS)

-11.12%

+12.83%

Nektar Therapeutics earnings per share and revenue

On Aug 13, 2026, NKTR reported earnings of -1.23 USD per share (EPS) for Q2 26, beating the estimate of -2.02 USD, resulting in a 39.24% surprise. Revenue reached 10.13 million, compared to an expected 10.63 million, with a -4.72% difference. The market reacted with a -3.82% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 8 analysts forecast an EPS of -2.11 USD, with revenue projected to reach 10.48 million USD, implying an increase of 71.54% EPS, and increase of 3.44% in Revenue from the last quarter.

FAQ

What were Nektar Therapeutics's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Nektar Therapeutics reported EPS of -$1.23, beating estimates by 39.24%, and revenue of $10.13M, -4.72% below expectations.

How did the market react to Nektar Therapeutics's Q2 2026 earnings?

The stock price moved down -3.82%, changed from $75.92 before the earnings release to $73.02 the day after.

When is Nektar Therapeutics expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Nektar Therapeutics's next earnings report?

Based on 8 analysts, Nektar Therapeutics is expected to report EPS of -$2.11 and revenue of $10.48M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.